Sevil Bavbek

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

Ian F. Tannock, Karim Fizazi, Camilla Thellenberg Karlsson et al. · The Lancet Oncology · 2013 · 287 citations

Medicine, Oncology, Pharmacology +16

An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy

Viktor Grünwald, Pierre I. Karakiewicz, Sevil Bavbek et al. · European Journal of Cancer · 2011 · 87 citations

Medicine, Oncology, Pharmacology +16

Record-3: Phase II randomized trial comparing sequential first-line everolimus (EVE) and second-line sunitinib (SUN) versus first-line SUN and second-line EVE in patients with metastatic renal cell carcinoma (mRCC).

Robert J. Motzer, Carlos H. Barrios, Tae Min Kim et al. · Journal of Clinical Oncology · 2013 · 70 citations

Medicine, Oncology, Pharmacology +16

Prognostic Factors and Survival in Late Adolescent and Adult Patients With Small Round Cell Tumors

Yeşim Eralp, Sevil Bavbek, Mert Başaran et al. · American Journal of Clinical Oncology · 2002 · 28 citations

Medicine, Oncology, Surgery +17

Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma.

Neşe Güney, Mert Başaran, Sevil Bavbek et al. · PubMed · 2009 · 27 citations

Medicine, Immunology, Pathology +14